ACS Central Science (Dec 2019)
Development of a Retinal-Based Probe for the Profiling of Retinaldehyde Dehydrogenases in Cancer Cells
- Sebastiaan T. A. Koenders,
- Lukas S. Wijaya,
- Martje N. Erkelens,
- Alexander T. Bakker,
- Vera E. van der Noord,
- Eva J. van Rooden,
- Lindsey Burggraaff,
- Pasquale C. Putter,
- Else Botter,
- Kim Wals,
- Hans van den Elst,
- Hans den Dulk,
- Bogdan I. Florea,
- Bob van de Water,
- Gerard J. P. van Westen,
- Reina E. Mebius,
- Herman S. Overkleeft,
- Sylvia E. Le Dévédec,
- Mario van der Stelt
Affiliations
- Sebastiaan T. A. Koenders
- Department of Molecular Physiology, Leiden Institute of Chemistry, Leiden University, Leiden, The Netherlands
- Lukas S. Wijaya
- Cancer Therapeutics and Drug Safety, Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands
- Martje N. Erkelens
- Department of Molecular Cell Biology and Immunology, Amsterdam University Medical Centra, Amsterdam, The Netherlands
- Alexander T. Bakker
- Department of Molecular Physiology, Leiden Institute of Chemistry, Leiden University, Leiden, The Netherlands
- Vera E. van der Noord
- Cancer Therapeutics and Drug Safety, Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands
- Eva J. van Rooden
- Department of Molecular Physiology, Leiden Institute of Chemistry, Leiden University, Leiden, The Netherlands
- Lindsey Burggraaff
- Computational Drug Discovery, Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands
- Pasquale C. Putter
- Department of Molecular Physiology, Leiden Institute of Chemistry, Leiden University, Leiden, The Netherlands
- Else Botter
- Department of Molecular Physiology, Leiden Institute of Chemistry, Leiden University, Leiden, The Netherlands
- Kim Wals
- Department of Molecular Physiology, Leiden Institute of Chemistry, Leiden University, Leiden, The Netherlands
- Hans van den Elst
- Department of Bio-Organic Synthesis, Leiden Institute of Chemistry, Leiden University, Leiden, The Netherlands
- Hans den Dulk
- Department of Molecular Physiology, Leiden Institute of Chemistry, Leiden University, Leiden, The Netherlands
- Bogdan I. Florea
- Department of Bio-Organic Synthesis, Leiden Institute of Chemistry, Leiden University, Leiden, The Netherlands
- Bob van de Water
- Cancer Therapeutics and Drug Safety, Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands
- Gerard J. P. van Westen
- Computational Drug Discovery, Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands
- Reina E. Mebius
- Department of Molecular Cell Biology and Immunology, Amsterdam University Medical Centra, Amsterdam, The Netherlands
- Herman S. Overkleeft
- Department of Bio-Organic Synthesis, Leiden Institute of Chemistry, Leiden University, Leiden, The Netherlands
- Sylvia E. Le Dévédec
- Cancer Therapeutics and Drug Safety, Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands
- Mario van der Stelt
- Department of Molecular Physiology, Leiden Institute of Chemistry, Leiden University, Leiden, The Netherlands
- DOI
- https://doi.org/10.1021/acscentsci.9b01022
- Journal volume & issue
-
Vol. 5,
no. 12
pp. 1965 – 1974
Abstract
No abstracts available.